LUMOS PHARMA INC. - C
3.8050
08-October-24 13:03:23
15 minutes delayed
Stocks
-0.0550
-1.42%
Today's range
3.6500 - 3.9400
ISIN
N/A
Source
NASDAQ
-
25 Sep 2024 16:05:00 By Nasdaq GlobeNewswire
-
Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024
05 Sep 2024 09:00:00 By Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
15 Aug 2024 09:00:00 By Nasdaq GlobeNewswire
-
Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update
01 Aug 2024 16:05:00 By Nasdaq GlobeNewswire
-
23 Jul 2024 16:05:00 By Nasdaq GlobeNewswire
-
Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
04 Jun 2024 09:00:00 By Nasdaq GlobeNewswire
-
Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024
20 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
14 May 2024 16:15:00 By Nasdaq GlobeNewswire
-
09 May 2024 14:51:02 By Nasdaq GlobeNewswire
-
Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
18 Apr 2024 16:05:00 By Nasdaq GlobeNewswire
-
20 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update
07 Mar 2024 16:01:00 By Nasdaq GlobeNewswire
-
Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024
26 Feb 2024 09:00:00 By Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conference
05 Feb 2024 16:05:01 By Nasdaq GlobeNewswire
-
21 Nov 2023 16:15:00 By Nasdaq GlobeNewswire
-
20 Nov 2023 16:05:00 By Nasdaq GlobeNewswire
-
Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates
07 Nov 2023 16:35:00 By Nasdaq GlobeNewswire
-
07 Nov 2023 16:01:00 By Nasdaq GlobeNewswire
-
26 Sep 2023 09:00:00 By Nasdaq GlobeNewswire
-
14 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >